ENTITY

Cellectis SA (ALCLS FP)

2
Analysis
Health CareFrance
Cellectis SA is a biopharmaceutical company focused on developing immunotherapies based on gene edited CAR-T cells (UCART). The company's mission is to develop a new generation of cancer therapies based on engineered T-cells.
more
Exchange Announcement04 Nov 2022 20:30
Exchange Announcement05 Aug 2022 10:13
Exchange Announcement13 May 2022 19:50
Exchange Announcement04 Mar 2022 10:37
Exchange Announcement05 Nov 2021 08:00
x